CytomX Therapeutics, Inc. - CTMX

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 26
Latest filed: Apr 16, 2026
Form Count
4 11
SCHEDULE 13G/A 9
8-K 3
SCHEDULE 13G 2
144 1

Latest files

Filed Form Report period Accession SEC
Apr 16, 2026 SCHEDULE 13G 0000902664-26-002013 View
Mar 26, 2026 SCHEDULE 13G/A 0000102909-26-001034 View
Mar 19, 2026 4 Mar 17, 2026 0001610717-26-000122 View
Mar 19, 2026 4 Mar 17, 2026 0001610717-26-000123 View
Mar 19, 2026 4 Mar 17, 2026 0001610717-26-000124 View
Mar 19, 2026 4 Mar 17, 2026 0001610717-26-000125 View
Mar 19, 2026 8-K Mar 17, 2026 0001193125-26-115958 View
Mar 16, 2026 8-K Mar 16, 2026 0001193125-26-107152 View
Mar 04, 2026 SCHEDULE 13G 0001907884-26-000006 View
Feb 17, 2026 SCHEDULE 13G/A 0001214659-26-002019 View
Feb 17, 2026 SCHEDULE 13G/A 0000947871-26-000190 View
Feb 05, 2026 SCHEDULE 13G/A 0000315066-26-000388 View
Feb 04, 2026 4 Feb 02, 2026 0001610717-26-000039 View
Feb 04, 2026 4 Feb 02, 2026 0001610717-26-000040 View
Feb 04, 2026 4 Feb 02, 2026 0001610717-26-000041 View
Feb 04, 2026 4 Feb 02, 2026 0001610717-26-000042 View
Feb 04, 2026 4 Feb 02, 2026 0001610717-26-000043 View
Nov 14, 2025 SCHEDULE 13G/A 0001013594-25-001422 View
Nov 14, 2025 SCHEDULE 13G/A 0000902664-25-005005 View
Nov 14, 2025 SCHEDULE 13G/A 0001738048-25-000016 View
Nov 10, 2025 4 Nov 06, 2025 0001610717-25-000372 View
Nov 07, 2025 SCHEDULE 13G/A 0000315066-25-002911 View
Nov 06, 2025 8-K Nov 06, 2025 0001193125-25-269533 View
Nov 06, 2025 144 0001628280-25-050396 View
Nov 05, 2025 SCHEDULE 13G/A 0000315066-25-002714 View
Oct 29, 2025 4 Oct 20, 2025 0001610717-25-000370 View